Subclasses list- 1 Azides
Patents: 42 Patent Applications: 36 - 2 With preservative or stabilizer
Patents: 1 Patent Applications: 0 - 3 Phoshorus attached directly or indirectly to the azide group by nonionic bonding
Patents: 8 Patent Applications: 3 - 4 Silicon, boron, aluminum or heavy metal containing
Patents: 30 Patent Applications: 3 - 5 Chalcogen or nitrogen bonded directly to the azide group (e.g., sulfonyl azides, etc.)
Patents: 21 Patent Applications: 2 - 6 Having -C(=X)-, wherein X is chalcogen, bonded directly to the azide group
Patents: 17 Patent Applications: 7 - 7 Chalcogen bonded directly to the -C(=X)- group
Patents: 12 Patent Applications: 0 - 8 Benzene ring bonded directly to the azide group
Patents: 84 Patent Applications: 9 - 9 Cyclopentanohydrophenanthrene ring system containing
Patents: 21 Patent Applications: 1 - 10 Acyclic carbon bonded directly to the azide group
Patents: 87 Patent Applications: 13 - 11 Nitrogen attached indirectly to the azide group by acyclic nonionic bonding (e.g., diazides, etc.)
Patents: 62 Patent Applications: 9 - 12 Having -C(=X)-, wherein X is chalcogen, attached indirectly to the azide group by acyclic nonionic bonding
Patents: 39 Patent Applications: 13 - 100 Acyclic carbon bonded directly to three benzene rings and to cyano (e.g., triphenylacetonitrile, etc.)
Patents: 10 Patent Applications: 0 - 101 Acyclic carbon bonded directly to three benzene rings or to two benzene rings and a cyclohexadienyl ring, which acyclic carbon may not be bonded to a fourth carbon (e.g., triphenylmethane dyestuffs, etc.)
Patents: 22 Patent Applications: 4 - 102 With preservative or stabilizer
Patents: 0 Patent Applications: 0 - 103 Heavy metal or alumium containing
Patents: 12 Patent Applications: 0 - 104 Nitrogen, sulfur, phosphorus, or peroxy attached directly to the acyclic carbon by nonionic bonding
Patents: 26 Patent Applications: 2 - 105 The acyclic carbon and an additional carbon are bonded directly to the same oxygen (ethers, esters, etc.)
Patents: 68 Patent Applications: 0 - 106 One of the rings, or a polycyclo ring system containing one of the rings, is bonded directly to -N=C=O or to -C(=O)OH (wherein H may be replaced by a group IA or IIA light metal, or by substituted or unsubstituted ammonium)
Patents: 19 Patent Applications: 0 - 107 Chalcogen bonded directly to the ring or ring system (e.g., salicyclic type, hydroxynaphthoic type, etc.)
Patents: 6 Patent Applications: 0 - 108 One of the rings is part of a polycyclo ring system (e.g., naphthyldiphenylcarbinol, etc.)
Patents: 27 Patent Applications: 0 - 109 An acyclic alkylene group is bonded directly to nitrogen and to chalcogen, cyano, carbonyl or additional nitrogen (e.g., N-hydroxyalkyl, N cyanoalkyl, N-sulfatoalkyl, aminoalkylamino groups, etc.)
Patents: 28 Patent Applications: 0 - 110 One of the rings and a benzene ring are bonded directly to the same nitrogen (e.g., triphenylrosaniline, etc.)
Patents: 35 Patent Applications: 0 - 111 Nitrogen, except as cyano, attached indirectly to a ring by acyclic nonionic bonding (e.g., benzyl rosanilines, etc.)
Patents: 30 Patent Applications: 1 - 112 Carbon bonded directly to -S(=O)(=O)OH (wherein H may be replaced by a group IA or IIA light metal, or by substituted or unsubstituted ammonium; i.e., sulfonic acids and salts thereof)
Patents: 8 Patent Applications: 0 - 113 Nitrogen bonded directly to one of the rings (e.g., malachite green, rosophenoline, etc.)
Patents: 31 Patent Applications: 0 - 114 Nitrogen bonded directly to each of the rings (e.g., rosaniline, crystal violet, etc.)
Patents: 26 Patent Applications: 0 - 115 Chalcogen bonded directly to one of the rings (e.g., fuchsone, etc.)
Patents: 23 Patent Applications: 0 - 200 Tetracyclo naphthacene configured ring system having at least one double bond between ring members and having oxygen bonded directly to a carbon of an interior ring which carbon is a member of one ring only
Patents: 15 Patent Applications: 3 - 201 Two oxygens double bonded directly to the interior ring in para positions
Patents: 119 Patent Applications: 5 - 202 At least six oxygens bonded directly to the tetracyclo ring system
Patents: 18 Patent Applications: 4 - 203 Nitrogen and carbonyl or cyano bonded directly to the tetracyclo ring system (e.g., tetracycline, etc.)
Patents: 44 Patent Applications: 44 - 204 Carbon double bonded directly to the tetracyclo ring system (e.g., 6 methylene tetracycline, etc.)
Patents: 24 Patent Applications: 9 - 205 Plural nitrogens bonded directly to the tetracyclo ring system
Patents: 41 Patent Applications: 38 - 206 Processes
Patents: 28 Patent Applications: 5 - 207 Heavy metal or aluminum containing material utilized
Patents: 19 Patent Applications: 2 - 208 Polycyclo ring system containing anthracene configured ring system having at least one double bond between ring members and having oxygen single bonded or any atom double bonded directly at the 9- and 10-positions (e.g., anthraquinones, etc.)
Patents: 98 Patent Applications: 6 - 209 Phosphorus, selenium, silicon, heavy metal or aluminum containing
Patents: 31 Patent Applications: 5 - 210 Nitrogen or carbon double bonded directly at the 9- or 10-position
Patents: 15 Patent Applications: 1 - 211 Sulfur bonded directly to oxygen which is single bonded directly at the 9- or 10-position
Patents: 2 Patent Applications: 0 - 212 The polycyclo ring system is bonded directly to an additional polycyclo ring system having at least three cyclos (e.g., plural anthracene configured ring systems bonded directly to each other, etc.)
Patents: 16 Patent Applications: 1 - 213 The polycyclo ring system and an additional polycyclo ring system having at least three cyclos are bonded directly to the same atom (e.g., plural anthracene configured ring systems bonded directly to the same sulfur, etc.)
Patents: 4 Patent Applications: 0 - 214 The atom is nitrogen (e.g., anthrimides, etc.)
Patents: 8 Patent Applications: 0 - 215 At least five cyclos in the polycyclo ring system
Patents: 3 Patent Applications: 0 - 216 The polycyclo ring system is tetracyclic
Patents: 6 Patent Applications: 2 - 217 Nitrogen, oxygen, sulfur, carbon or halogen bonded directly at beta position of the anthracene configured ring system (i.e., 2-, 3-, 6- or 7 position)
Patents: 3 Patent Applications: 0 - 218 The polycyclo ring system is attached indirectly by nonionic bonding to an additional polycyclo ring system having at least three cyclos (e.g., plural anthracene ring systems attached indirectly to each other by nonionic bonding, etc.)
Patents: 10 Patent Applications: 1 - 219 Nitrogen, oxygen, sulfur, carbon or halogen bonded directly at beta position of the anthracene configured ring system (i.e. 2-, 3-, 6- or 7 position)
Patents: 8 Patent Applications: 0 - 220 The polycyclo ring system contains at least four cyclos
Patents: 19 Patent Applications: 3 - 221 Sulfur bonded directly at beta position (i.e., 2-, 3-, 6- or 7-position)
Patents: 21 Patent Applications: 0 - 222 Nitrogen or additional sulfur bonded directly to the sulfur
Patents: 9 Patent Applications: 1 - 223 Additional carbon bonded directly to the sulfur
Patents: 28 Patent Applications: 0 - 224 Carbonyl, nitrogen, oxygen or halogen bonded directly at beta position (i.e., 2-, 3-, 6- or 7-position)
Patents: 29 Patent Applications: 0 - 225 Nitrogen bonded directly at alpha position (i.e., 1-, 4-, 5- or 8-position)
Patents: 34 Patent Applications: 0 - 226 Oxygen, sulfur or halogen bonded directly at alpha position (i.e., 1-, 4-, 5- or 8-position)
Patents: 28 Patent Applications: 1 - 227 Plural nitrogens, plural oxygens, plural sulfurs, or plural halogens bonded directly at alpha positions
Patents: 18 Patent Applications: 2 - 228 Additional ring containing
Patents: 26 Patent Applications: 1 - 229 Containing cyano or containing nitrogen bonded directly to sulfur (e.g., sulfonamide containing, etc.)
Patents: 11 Patent Applications: 0 - 230 Acyclic carbonyl or thiocarbonyl containing (e.g., thiocarboxamide containing, etc.)
Patents: 25 Patent Applications: 0 - 231 Oxygen, sulfur or halogen bonded directly to the additional ring
Patents: 13 Patent Applications: 0 - 232 Oxygen, sulfur, nitro or halogen bonded directly to the additional ring
Patents: 23 Patent Applications: 0 - 233 Plural additional rings containing
Patents: 10 Patent Applications: 0 - 234 Sulfur bonded directly at alpha position (i.e., 1-, 4-, 5- or 8-position)
Patents: 38 Patent Applications: 0 - 235 Nitrogen or halogen bonded directly to the anthracene configured ring system
Patents: 38 Patent Applications: 1 - 236 Nitrogen bonded directly at beta position (i.e., 2-, 3-, 6- or 7-position)
Patents: 42 Patent Applications: 1 - 237 Oxygen, nitrogen or additional carbon bonded directly to the nitrogen
Patents: 63 Patent Applications: 0 - 238 Nitrogen bonded directly at alpha position (i.e., 1-, 4-, 5- or 8-position)
Patents: 81 Patent Applications: 7 - 239 Cyano bonded directly to the anthracene configured ring system
Patents: 30 Patent Applications: 1 - 240 Oxygen bonded directly at beta position (i.e., 2-, 3-, 6- or 7-position)
Patents: 29 Patent Applications: 1 - 241 Additional carbon bonded directly to the oxygen
Patents: 40 Patent Applications: 1 - 242 The additional carbon is part of a ring
Patents: 40 Patent Applications: 1 - 243 Oxygen bonded directly at alpha position (i.e., 1-, 4-, 5- or 8-position)
Patents: 45 Patent Applications: 2 - 244 Halogen bonded directly to the anthracene configured ring system
Patents: 47 Patent Applications: 4 - 245 Carbon bonded directly to the anthracene configured ring system
Patents: 37 Patent Applications: 1 - 246 Oxygen bonded directly to the nitrogen (e.g., nitro bonded directly at 8 position, etc.)
Patents: 28 Patent Applications: 1 - 247 Additional carbon bonded directly to the nitrogen
Patents: 58 Patent Applications: 2 - 248 Cyano, carboxamide, sulfonamide or halogen containing
Patents: 24 Patent Applications: 0 - 249 Halogen bonded directly to the anthracene configured ring system
Patents: 61 Patent Applications: 0 - 250 Carbonyl, oxygen or sulfur bonded directly to he nitrogen
Patents: 17 Patent Applications: 1 - 251 Carbon bonded directly to the anthracene configured ring system
Patents: 54 Patent Applications: 0 - 252 Nitrogen or halogen bonded directly to the carbon (e.g., carboxamide bonded directly to the anthracene configured ring system, etc.)
Patents: 14 Patent Applications: 0 - 253 Oxygen or sulfur bonded directly to the nitrogen (e.g., 1- nitroanthraquinone, etc.)
Patents: 44 Patent Applications: 0 - 254 Plural nitrogens bonded directly at alpha positions (i.e., 1-, 4-, 5- or 8 positions, e.g., 1, 5- dinitroanthraquinones, etc.)
Patents: 48 Patent Applications: 0 - 255 Additional carbon bonded directly to the nitrogen
Patents: 64 Patent Applications: 2 - 256 The additional carbon is part of a carbonyl group (i.e., carboxamido bonded directly at alpha position)
Patents: 21 Patent Applications: 1 - 257 Nitrogen, oxygen, sulfur or halogen bonded directly to an additional ring
Patents: 10 Patent Applications: 0 - 258 The additional carbon is part of a ring or ring system
Patents: 53 Patent Applications: 0 - 259 Oxygen, sulfur or halogen bonded directly to the ring or ring system
Patents: 29 Patent Applications: 1 - 260 Acyclic carbonyl, sulfur or halogen containing
Patents: 25 Patent Applications: 0 - 261 Oxygen bonded directly at beta position (i.e., 2-, 3-, 6- or 7-position)
Patents: 41 Patent Applications: 4 - 262 Oxygen bonded directly at alpha position (i.e., 1-, 4-, 5-, or 8-position)
Patents: 70 Patent Applications: 6 - 263 Halogen bonded directly at beta position (i.e., 2-, 3-, 6-, or 7-position)
Patents: 23 Patent Applications: 0 - 264 Halogen bonded directly at alpha position (i.e., 1-, 4-, 5- or 8-position)
Patents: 24 Patent Applications: 0 - 265 Carbon bonded directly at beta position (i.e., 2-, 3-, 6- or 7-position)
Patents: 38 Patent Applications: 0 - 266 Nitrogen, halogen or additional oxygen containing
Patents: 21 Patent Applications: 1 - 267 Carbon bonded directly at alpha position (i.e., 1-, 4-, 5- or 8-position)
Patents: 28 Patent Applications: 0 - 268 Processes of forming anthraquinone per se or enolic form thereof by reacting an organic acid, aldehyde, anhydride or an indane (e.g., reacting phthalic anhydride, methyl phenylindane, etc.)
Patents: 30 Patent Applications: 2 - 269 Processes of forming anthraquinone per se or enolic form thereof utilizing heavy metal containing material (e.g., vanadium catalyst utilized, etc.)
Patents: 17 Patent Applications: 0 - 270 Light metal or nitrogen containing material utilized (e.g., ceric ammonium nitrate catalyst utilized, etc.)
Patents: 16 Patent Applications: 0 - 271 Polycyclo ring system containing anthracene configured ring system having at least one double bond between ring members and having oxygen single bonded or any atom double bonded direct at the 9- or 10-position (e.g., anthrones, anthranois, etc.)
Patents: 16 Patent Applications: 2 - 272 Phosphorus, selenium, tellurium, or heavy metal containing
Patents: 3 Patent Applications: 0 - 273 The polycyclo ring system is bonded directly to an additional polycyclo ring system having at least three cyclo (e.g., plural anthracene configured ring systems bonded directly to each other, etc.)
Patents: 3 Patent Applications: 0 - 274 The polycyclo ring system is attached indirectly by nonionic bonding to an additional polycyclo ring system having a least three cyclos (e.g., plural anthracene configured ring systems bonded directly to the same nitrogen, etc.)
Patents: 3 Patent Applications: 1 - 275 The polycyclo ring system has at least ten cyclos
Patents: 0 Patent Applications: 0 - 276 The polycyclo ring system has nine cyclos
Patents: 7 Patent Applications: 0 - 277 Cyano, nitrogen or sulfur bonded directly to the nonacyclo ring system
Patents: 2 Patent Applications: 0 - 278 Halogen containing or processes wherein a halogen containing material is utilized
Patents: 2 Patent Applications: 0 - 279 Oxygen single bonded directly to the nonacyclo ring system
Patents: 7 Patent Applications: 0 - 280 Halogen or light metal containing or processes wherein a halogen or light metal containing is utilized
Patents: 4 Patent Applications: 0 - 281 Halogen containing
Patents: 6 Patent Applications: 0 - 282 The polycyclo ring system has seven or eight cyclos
Patents: 11 Patent Applications: 0 - 283 Halogen containing
Patents: 4 Patent Applications: 0 - 284 The polycyclo ring system has five of six cyclos
Patents: 13 Patent Applications: 4 - 285 Halogen containing
Patents: 3 Patent Applications: 0 - 286 The polycyclo ring system has four cyclos (e.g., benzanthrones, etc.)
Patents: 14 Patent Applications: 0 - 287 Cyano, carbonyl, nitrogen or sulfur bonded directly to the tetracyclo ring system
Patents: 11 Patent Applications: 0 - 288 Halogen or carbon bonded directly to the tetracyclo ring system
Patents: 9 Patent Applications: 0 - 289 Nitrogen or sulfur bonded directly to the anthracene configured ring system
Patents: 9 Patent Applications: 0 - 290 Carbon, halogen or plural oxygens bonded directly to the anthracene configured ring system
Patents: 34 Patent Applications: 0 - 291 Cyclohexadiene having atoms double bonded directly at the 1- and 2- positions (e.g., orthoquinones, etc.)
Patents: 39 Patent Applications: 1 - 292 Polycyclo ring system having the cyclohexadiene as one of the cyclos
Patents: 39 Patent Applications: 7 - 293 Cyclohexadiene having atoms double bonded directly at the 1- and 4- positions (e.g., paraquinones, etc.)
Patents: 57 Patent Applications: 8 - 294 Phosphorus, heavy metal or aluminum containing
Patents: 15 Patent Applications: 8 - 295 Polycyclo ring system having the cyclohexadiene as one of the cyclos
Patents: 23 Patent Applications: 2 - 296 Oxygen double bonded directly at the 1- and 4- positions
Patents: 55 Patent Applications: 6 - 297 Nitrogen or halogen bonded directly to the polycyclo ring system
Patents: 33 Patent Applications: 2 - 298 Chalcogen single bonded directly to the polycyclo ring system
Patents: 62 Patent Applications: 4 - 299 Carbon bonded directly to the polycyclo ring system
Patents: 66 Patent Applications: 1 - 300 Plural oxygens and plural nitrogens bonded directly to the polycyclo ring system
Patents: 1 Patent Applications: 0 - 301 Nitrogen double bonded directly at the 1- and 4- positions
Patents: 26 Patent Applications: 5 - 302 Nitrogen double bonded directly at the 1- or 4- positions
Patents: 45 Patent Applications: 6 - 303 Carbon double bonded directly at the 1- and 4- positions
Patents: 28 Patent Applications: 2 - 304 Carbon double bonded directly at the 1- or 4- position
Patents: 48 Patent Applications: 0 - 305 Sulfur bonded directly at the 2-, 3-, 5- or 6- position
Patents: 4 Patent Applications: 0 - 306 Nitrogen bonded directly at the 2-, 3-, 5- or 6- position
Patents: 11 Patent Applications: 2 - 307 Oxygen bonded directly at the 2-, 3-, 5-, or 6- position
Patents: 58 Patent Applications: 10 - 308 Halogen bonded directly at the 2-, 3-, 5-, or 6- position
Patents: 27 Patent Applications: 0 - 309 Carbon donded directly at the 2-, 3-, 5- or 6- position
Patents: 59 Patent Applications: 4 - 310 At least three carbons bonded directly to the cyclohexadiene
Patents: 65 Patent Applications: 1 - 500 Cyclopentanohydrophenanthrene ring system wherein two nonadjacent carbons of the ring system are bonded directly to each other (e.g., 3,5 cyclocholesterols, 3,5-cycloandrostanes, etc.)
Patents: 14 Patent Applications: 3 - 501 Oxygen bonded directly at the 6-position of the cyclopentanohydrophenanthrene ring system
Patents: 37 Patent Applications: 0 - 502 Cyclopentanohydrophenanthrene ring system containing
Patents: 105 Patent Applications: 45 - 503 With preservative or stabilizer
Patents: 8 Patent Applications: 2 - 504 Heavy metal or aluminum containing
Patents: 35 Patent Applications: 5 - 505 Boron, silicon, selenium or tellurium containing
Patents: 187 Patent Applications: 12 - 506 Phosphorus attached directly or indirectly to the cyclopentanohydrophenanthrene ring system by nonionic bonding
Patents: 61 Patent Applications: 23 - 507 The phosphorus is bonded directly at the 21-position or is bonded directly to a chalcogen which is bonded directly at the 21-positon
Patents: 36 Patent Applications: 0 - 508 Spiro
Patents: 25 Patent Applications: 8 - 509 Plural cyclopentanohydrophenanthrene ring systems
Patents: 30 Patent Applications: 9 - 510 The cyclopentanohydrophenanthrene ring system is part of a polycyclo ring system having at least five cyclos
Patents: 81 Patent Applications: 20 - 511 The additional ring shares the 1,2-positions of the cyclopentanohydrophenanthrene ring system
Patents: 37 Patent Applications: 20 - 512 The additional ring shares the 5,10- or 5,19-positions of the cyclopentanohydrophenanthrene ring system
Patents: 3 Patent Applications: 1 - 513 The additional ring shares the 6,7-positions of the cyclopentanohydrophenanthrene ring system
Patents: 18 Patent Applications: 4 - 514 The additional ring shares the 16,17-positions of the cyclopentanohydrophenanthrene ring system
Patents: 26 Patent Applications: 16 - 515 Nitrogen bonded directly to the cyclopentanohydrophenanthrene ring system
Patents: 67 Patent Applications: 14 - 516 The nitrogen is double bonded to the cyclopentanohydrophenanthrene ring system
Patents: 11 Patent Applications: 4 - 517 The nitrogen is part of a semicarbazone or thiosemicarbazone group
Patents: 5 Patent Applications: 1 - 518 Additional nitrogen bonded directly to the nitrogen (e.g., hydrazones, etc.)
Patents: 21 Patent Applications: 5 - 519 Oxygen bonded directly to the nitrogen (e.g., oximes, isonitrosos, etc.)
Patents: 34 Patent Applications: 2 - 520 The nitrogen is bonded directly at the 3-position
Patents: 56 Patent Applications: 11 - 521 The nitrogen is bonded directly at the 3-position
Patents: 52 Patent Applications: 10 - 522 The nitrogen is bonded directly at the 17-position
Patents: 34 Patent Applications: 4 - 523 Sulfur bonded directly to the cyclopentanohydrophenanthrene ring system
Patents: 40 Patent Applications: 3 - 524 The sulfur is bonded directly at the 1- or 3-position
Patents: 15 Patent Applications: 0 - 525 The sulfur is bonded directly at the 16- or 17-position
Patents: 38 Patent Applications: 1 - 526 Carbon double bonded directly to the cyclopentanohydrophenantrene ring system
Patents: 73 Patent Applications: 9 - 527 The carbon is double bonded directly at the 2-position
Patents: 13 Patent Applications: 0 - 528 The carbon is double bonded directly at the 16-position
Patents: 36 Patent Applications: 1 - 529 And carbon bonded directly at the 17 beta-position is a member of an acyclic chain of two or more uninterrupted carbons
Patents: 48 Patent Applications: 2 - 530 The carbon is double bonded directly at the 17-position (e.g., fusidic acids, etc.)
Patents: 46 Patent Applications: 3 - 531 Nitrogen or sulfur containing
Patents: 47 Patent Applications: 3 - 532 The carbon is a member of an acyclic chain of exactly two carbons (e.g., 3 keto-4,17(20)-pregnadienes, 17-ethylidene-estranes,etc.)
Patents: 29 Patent Applications: 0 - 533 Plural oxygens bonded directly to the cyclopentanohydrophenanthrene ring system
Patents: 16 Patent Applications: 1 - 534 And oxygen bonded directly at the 21-position of the compound
Patents: 15 Patent Applications: 0 - 535 Halogen bonded directly at the 12-position of the cyclopentanohydrophenanthrene ring system
Patents: 2 Patent Applications: 0 - 536 Halogen bonded directly at the 16-position of the cyclopentanohydrophenanthrene ring system
Patents: 26 Patent Applications: 1 - 537 Plural halogens bonded directly at the 16-position
Patents: 2 Patent Applications: 0 - 538 Carbon bonded directly at the 17 beta-position is a member of an acyclic chain of two or more uninterrupted carbons
Patents: 21 Patent Applications: 0 - 539 Halomethyl bonded directly to the cyclopentanohydrophenanthrene ring system (e.g., 16-trifluoromethyl progesterones, etc.)
Patents: 41 Patent Applications: 1 - 540 Carbon bonded directly at the 17 beta-position of the cyclopentanohydrophenanthrene ring system is a member of an acyclic chain of six or more uninterrupted carbons (e.g., sterols, etc.)
Patents: 102 Patent Applications: 39 - 541 Oxygen bonded directly at the 1-, 2-, or 4-position
Patents: 82 Patent Applications: 10 - 542 Oxygen bonded directly at the 6- or 7-position
Patents: 68 Patent Applications: 8 - 543 Carbon or halogen bonded directly at the 6- or 7-position
Patents: 26 Patent Applications: 5 - 544 Exactly one oxygen bonded directly to the cyclopentanohydrophenanthrene ring system (e.g., cholesterols, cholestanols, stigmasterols, etc.)
Patents: 208 Patent Applications: 33 - 545 Processes of isolating, purifying or recovering from animal, vegetable or fungal sources (e.g., wool fat or grease, lanolin, fish oils, animal tissue, soybean oil, tall oil or pitch, wood products, sugar cane, soap stocks, yeast, molds, etc.)
Patents: 93 Patent Applications: 11 - 546 Halogen or oxygen bonded directly to the acyclic carbon chain at the 17 beta-position (e.g., 25-hydroxy cholesterols, etc.)
Patents: 92 Patent Applications: 5 - 547 Unsaturation between the 7- and 8-positions (e.g., ergosterols, 7 dehydrocholesterols, provitamin D, etc.)
Patents: 43 Patent Applications: 6 - 548 Carbon bonded directly at the 17 beta-position of the cyclopentanohydrophenanthrene ring system is a member of an acyclic chain of five uninterrupted carbons (e.g., choladienes, cholanic acids, etc.) stocks, yeast, molds, etc.)
Patents: 74 Patent Applications: 3 - 549 Oxygen bonded directly at the 12-position (e.g., cholic acids, desoxycholic acids, dehydrocholic acids, etc.)
Patents: 49 Patent Applications: 3 - 550 Halogen, nitrogen, or sulfur containing (e.g., glycocholic acids, taurocholic acids, etc.)
Patents: 40 Patent Applications: 8 - 551 Oxygen bonded directly at the 6- or 7-position (e.g., chenodeoxycholic acids, ursodeoxycholic acids, etc.)
Patents: 77 Patent Applications: 7 - 552 Exactly one oxygen bonded directly to the cyclopentanohydrophenanthrene ring system (e.g., 3-hydroxycholanic acids, lithocholic acids, etc.)
Patents: 95 Patent Applications: 6 - 553 Carbon bonded directly at the 17 beta-position of the cyclopentanohydrophenanthrene ring system is a member of an acyclic chain of three or four uninterruped carbons, (e.g., diketobisnorcholenic acids, etc.)
Patents: 99 Patent Applications: 33 - 554 Halogen or nitrogen containing (e.g., 20-cyano-pregnanes, 21-cyano pregnenes, etc.)
Patents: 116 Patent Applications: 12 - 555 Exactly one oxygen bonded directly to the cyclopentanohydrophenanthrene ring system (e.g., 3-keto-bisnorcholenic acids, 3-keto-bisnor-cholene-22 als, etc.)
Patents: 63 Patent Applications: 5 - 556 And oxygen bonded directly at the 20-position of the compound
Patents: 28 Patent Applications: 1 - 557 Carbon bonded directly at the 17-beta-position of the cyclopentanohydrophenanthrene ring system is a member of an acyclic chain of two uninterrupted carbons (e.g., pregnanes, etc.)
Patents: 32 Patent Applications: 3 - 558 The A ring is a benzene ring
Patents: 53 Patent Applications: 9 - 559 Three or more oxygens bonded directly to the cyclopentanohydrophenanthrene ring system
Patents: 22 Patent Applications: 1 - 560 Oxygen bonded directly at the 1-, 2- or 4-position
Patents: 16 Patent Applications: 1 - 561 Oxygen bonded directly at the 6-position
Patents: 15 Patent Applications: 0 - 562 Oxygen bonded directly at the 7-, 8- or 9-position
Patents: 21 Patent Applications: 6 - 563 Oxygen bonded directly at the 14- or 15-position
Patents: 14 Patent Applications: 0 - 564 Oxygen bonded directly at the 16-position
Patents: 25 Patent Applications: 0 - 565 Carbon or halogen bonded directly at the 6- or 7-position
Patents: 52 Patent Applications: 0 - 566 Oxygen bonded directly at the 21-position (e.g., triamcinolone, etc.)
Patents: 51 Patent Applications: 4 - 567 Halogen bonded directly at the 2- or 4-position (e.g., 4-bromocortisones, etc.)
Patents: 25 Patent Applications: 0 - 568 The cyclopentanohydrophenanthrene ring system is fully saturated
Patents: 11 Patent Applications: 0 - 569 Oxygen bonded directly at the 3-, 11-, and 17-positions
Patents: 26 Patent Applications: 2 - 570 Oxygen bonded directly at the 21-position
Patents: 13 Patent Applications: 1 - 571 Carbon bonded directly at the 1-, 2- or 4-position
Patents: 12 Patent Applications: 0 - 572 Carbon or halogen bonded directly at the 6- or 7-position
Patents: 73 Patent Applications: 3 - 573 Carbon bonded directly at the 16-position
Patents: 70 Patent Applications: 1 - 574 Carbon bonded directly at the 16-position (e.g., betamethasones, dexamethasones, etc.)
Patents: 89 Patent Applications: 8 - 575 Nitrogen or sulfur containing
Patents: 53 Patent Applications: 7 - 576 Unsaturation between the 1- and 2-positions and the 4- and 5-positions (e.g., prednisones, prednisolones, etc.)
Patents: 61 Patent Applications: 2 - 577 Unsaturation between the 4- and 5-positions (e.g., cortisones, etc.)
Patents: 58 Patent Applications: 4 - 578 Additional unsaturation in the cyclopentanohydrophenanthrene ring system
Patents: 12 Patent Applications: 0 - 579 The cyclopentanohydrophenanthrene ring system is fully saturated
Patents: 10 Patent Applications: 0 - 580 Carbon or halogen bonded directly at the 6- or 7-position
Patents: 45 Patent Applications: 2 - 581 Unsaturation between the 4- and 5-positions (e.g., 21-thiol prednisones, 21 thio cortisones, etc.)
Patents: 60 Patent Applications: 3 - 582 Two oxygens bonded directly to the cyclopentanohydrophenanthrene ring system
Patents: 42 Patent Applications: 5 - 583 Oxygen bonded directly at the 5-, 6- or 7-position
Patents: 20 Patent Applications: 0 - 584 Oxygen bonded directly at the 12-position
Patents: 8 Patent Applications: 0 - 585 Oxygen bonded directly at the 15- or 16-position
Patents: 17 Patent Applications: 0 - 586 Oxygen bonded directly at the 3- and 11-position
Patents: 15 Patent Applications: 1 - 587 Oxygen bonded directly at the 21-position
Patents: 16 Patent Applications: 1 - 588 Unsaturation between the 4- and 5-positions (e.g., aldosterones, corticosterones, etc.)
Patents: 70 Patent Applications: 1 - 589 Carbon bonded directly at the 16-position
Patents: 27 Patent Applications: 0 - 590 Unsaturation between the 4- and 5-positions
Patents: 34 Patent Applications: 1 - 591 The cyclopentanohydrophenanthrene ring system is fully saturated
Patents: 13 Patent Applications: 0 - 592 Oxygen bonded directly at the 3- and 17-positions
Patents: 38 Patent Applications: 7 - 593 Oxygen bonded directly at the 21-position
Patents: 34 Patent Applications: 0 - 594 Carbon or halogen bonded directly at the 6- or 7-position
Patents: 66 Patent Applications: 1 - 595 Unsaturation between the 4- and 5-positions (e.g., 17-alpha-hydroxy progesterones, etc.)
Patents: 97 Patent Applications: 4 - 596 Carbon bonded directly at the 16-position
Patents: 52 Patent Applications: 0 - 597 Carbon or halogen bonded directly at the 6- or 7-position
Patents: 54 Patent Applications: 3 - 598 Unsaturation between the 4- and 5-positions
Patents: 83 Patent Applications: 5 - 599 Exactly one oxygen bonded directly to the cyclopentanohydrophenanthrene ring system
Patents: 34 Patent Applications: 7 - 600 Oxygen bonded directly at the 21-position
Patents: 32 Patent Applications: 3 - 601 Unsaturation between the 4- and 5-position (e.g., desoxycorticosterones, etc.)
Patents: 50 Patent Applications: 2 - 602 Additional unsaturation in the cyclopentanohydrophenanthrene ring system
Patents: 73 Patent Applications: 1 - 603 Carbon or halogen bonded directly at the 1-, 2-, 3-, 4- or 5-position
Patents: 31 Patent Applications: 2 - 604 Carbon bonded directly at the 16-position (e.g., 16-cyanopregn-4-ene-3, 20 diones, etc.)
Patents: 36 Patent Applications: 0 - 605 Carbon or halogen bonded directly at the 6- or 7-position
Patents: 25 Patent Applications: 0 - 606 Unsaturation between the 5- and 6-positions (e.g., pregnenolones, etc.)
Patents: 34 Patent Applications: 1 - 607 Unsaturation between the 4- and 5-positions (e.g., progesterones, etc.)
Patents: 52 Patent Applications: 4 - 608 Additional unsaturation in the cyclopentanohydrophenanthrene ring system
Patents: 55 Patent Applications: 1 - 609 The cyclopentanohydrophenanthrene ring system is fully saturated (e.g., pregnandiols, pregnanolones, etc.)
Patents: 23 Patent Applications: 3 - 610 Acyclic carbon bonded directly at the 17 beta-position of the cyclopentanohydrophenanthrene ring system (e.g., etiocholanic acids, 17 cyanoetiocholanes, 17-aldehydrostanes, etc.)
Patents: 114 Patent Applications: 31 - 611 Exactly one oxygen bonded directly to the cyclopentanohydrophenanthrene ring system (e.g., 3-keto-etiocholanic acids, etc.)
Patents: 64 Patent Applications: 8 - 612 Three or more oxygens bonded directly to the cyclopentanohydrophenanthrene ring system
Patents: 60 Patent Applications: 10 - 613 Oxygen bonded directly at the 1-position
Patents: 34 Patent Applications: 1 - 614 Oxygen bonded directly at the 2- or 4-position
Patents: 38 Patent Applications: 3 - 615 Oxygen bonded directly at the 5-, 6- or 7-position
Patents: 67 Patent Applications: 13 - 616 Oxygen bonded directly at the 16-position
Patents: 17 Patent Applications: 4 - 617 The A ring is a benzene ring (e.g., estriols, etc.)
Patents: 38 Patent Applications: 5 - 618 The A ring is a benzene ring
Patents: 44 Patent Applications: 7 - 619 Oxygen bonded directly at the 3-, 11- and 17-positions (e.g., 1-androstene 3,11,17-triones, etc.)
Patents: 33 Patent Applications: 2 - 620 Carbon or halogen bonded directly at the 1, 2- or 4-position
Patents: 13 Patent Applications: 0 - 621 Unsaturation between the 4- and 5-positions (e.g., adrenosterones, 11 hydroxytestosterones, etc.)
Patents: 34 Patent Applications: 0 - 622 17 alpha-position substituted (e.g., 11-keto-17 alpha-alkyltestosterones, etc.)
Patents: 33 Patent Applications: 0 - 623 Two oxygens bonded directly to the cyclopentanohydrophenanthrene ring system
Patents: 25 Patent Applications: 24 - 624 Oxygen bonded directly at the 16-position
Patents: 14 Patent Applications: 2 - 625 The A ring is a benzene ring (e.g., estrones, estradiols, etc.)
Patents: 106 Patent Applications: 30 - 626 Nitrogen or sulfur containing
Patents: 94 Patent Applications: 30 - 627 Carbon or halogen bonded directly at the 1-, 2- or 4-position
Patents: 27 Patent Applications: 1 - 628 Carbon or halogen bonded directly at the 6- or 7-position
Patents: 21 Patent Applications: 4 - 629 Carbon bonded directly at the 11-, 15- or 16-position
Patents: 29 Patent Applications: 1 - 630 17 alpha-position substituted
Patents: 34 Patent Applications: 2 - 631 The 17 alpha-position substituent contains acyclic carbon-to-carbon unsaturation
Patents: 24 Patent Applications: 1 - 632 19-position substituted (e.g., 19-methylene-androstanes, 10-cyanoestranes, etc.)
Patents: 38 Patent Applications: 3 - 633 Carbon bonded directly at the 10- and 13-positions (e.g., androstenes, etc.)
Patents: 30 Patent Applications: 3 - 634 Carbon or halogen bonded directly at the 1- or 3-position
Patents: 28 Patent Applications: 1 - 635 Carbon or halogen bonded directly at the 2- or 4-position
Patents: 28 Patent Applications: 1 - 636 Unsaturation between the 5- and 6-positions (e.g., dehydroandrosterones, etc.)
Patents: 51 Patent Applications: 3 - 637 17 alpha-position substituted (e.g., 17 alpha-ethynyl-5-androstene-3 beta, 17 beta-diols, etc.)
Patents: 24 Patent Applications: 1 - 638 Unsaturation between the 4- and 5-positions (e.g., testosterones, etc.)
Patents: 51 Patent Applications: 2 - 639 17 alpha-position substituted (e.g., 17 alpha-alkynylandrosta-4, 6-diene 3,17-diols, etc.)
Patents: 62 Patent Applications: 2 - 640 Additional unsaturation in the cyclopentanohydrophenanthrene ring system
Patents: 31 Patent Applications: 1 - 641 The cyclopentanohydrophenanthrene ring system is fully saturated (e.g., androstandiols, androsterones, dihydrotestosterones, etc.)
Patents: 43 Patent Applications: 3 - 642 Carbon bonded directly at the 13-position (e.g., 19-norandrostenes, estradienes, etc.)
Patents: 30 Patent Applications: 1 - 643 Carbon or halogen bonded directly at the 1-, 2-, 4- or 5-position
Patents: 18 Patent Applications: 0 - 644 Unsaturation between the 5- and 10-positions
Patents: 22 Patent Applications: 0 - 645 17 alpha-position substituted (e.g., 17 alpha-ethynyl-17-hydroxy-5(10) estren-3-ones, etc.)
Patents: 22 Patent Applications: 1 - 646 Unsaturation between the 4- and 5-positions (e.g., 19-nortestosterones, 13 beta-alkyl-4-gonene-3,17-diones etc.)
Patents: 68 Patent Applications: 5 - 647 Carbon or halogen bonded directly at the 6- or 7-position
Patents: 29 Patent Applications: 1 - 648 17 alpha-position substituted (e.g., 17 alpha-ethynyl-19 nortestosterones, etc.)
Patents: 90 Patent Applications: 1 - 649 The cyclopentanohydrophenanthrene ring system is fully saturated (e.g., 17 alpha-alkyl-17 beta-hydroxyestran-3-ones, etc.)
Patents: 11 Patent Applications: 0 - 650 Oxygen bonded directly at the 16- or 17-position of the cyclopentanohydrophenanthrene ring system
Patents: 53 Patent Applications: 11 - 651 Carbon or halogen bonded directly at the 1- or 3-position
Patents: 21 Patent Applications: 1 - 652 Carbon or halogen bonded directly at the 2-, 4- or 5-position
Patents: 13 Patent Applications: 1 - 653 9,10-Seco-cyclopentanohydrophenanthrene ring system or 9,10-seco cyclopentanohydrophenanthrene ring system having a bond between the 3- and 5-positions (e.g., vitamin D compounds, cholecalciferols, activated 7-dehydrocholesterols, dihydrotachysterols, 3,5 cyclovitamin D compounds, etc.)
Patents: 410 Patent Applications: 144
| |
Bizarre Patents 
PatentStorm News
Patents 
